Видео ютуба по тегу Novartis Rna Deal

Novartis x Arrowhead? The RNAi Deal That Could Reshape Cardiometabolic Pharma
Novartis x Arrowhead? The RNAi Deal That Could Reshape Cardiometabolic Pharma
Novartis Acquires Avidity Biosciences: $12 Billion Deal for RNA Platform
Novartis Acquires Avidity Biosciences: $12 Billion Deal for RNA Platform
Novartis makes $12bn wager on RNA drugs with Avidity buy #pharmanews #pharma #news #biotechnews
Novartis makes $12bn wager on RNA drugs with Avidity buy #pharmanews #pharma #news #biotechnews
Novartis' $12 Billion Deal: Unlocking RNA Therapeutics
Novartis' $12 Billion Deal: Unlocking RNA Therapeutics
Ep. 329 - Novartis' $12B Avidity Buy. Plus: Base Editors
Ep. 329 - Novartis' $12B Avidity Buy. Plus: Base Editors
Biggest Biotech Deal of 2025 Explained!
Biggest Biotech Deal of 2025 Explained!
Novartis + Regulus: RNAi Expands Beyond the Liver
Novartis + Regulus: RNAi Expands Beyond the Liver
💊 𝗡𝗢𝗩𝗔𝗥𝗧𝗜𝗦 𝗕𝗨𝗬𝗦 𝗥𝗘𝗚𝗨𝗟𝗨𝗦 𝗙𝗢𝗥 $𝟭.𝟳𝗕: 𝗧𝗛𝗘 𝗚𝗔𝗠𝗘-𝗖𝗛𝗔𝗡𝗚𝗜𝗡𝗚 𝗠𝗜𝗥𝗡𝗔𝗔 𝗗𝗥𝗨𝗚 𝗕𝗘𝗛𝗜𝗡𝗗 𝗧𝗛𝗘 𝗗𝗘𝗔𝗟!
💊 𝗡𝗢𝗩𝗔𝗥𝗧𝗜𝗦 𝗕𝗨𝗬𝗦 𝗥𝗘𝗚𝗨𝗟𝗨𝗦 𝗙𝗢𝗥 $𝟭.𝟳𝗕: 𝗧𝗛𝗘 𝗚𝗔𝗠𝗘-𝗖𝗛𝗔𝗡𝗚𝗜𝗡𝗚 𝗠𝗜𝗥𝗡𝗔𝗔 𝗗𝗥𝗨𝗚 𝗕𝗘𝗛𝗜𝗡𝗗 𝗧𝗛𝗘 𝗗𝗘𝗔𝗟!
Novartis to Acquire Avidity Biosciences: A Major Biotech Deal
Novartis to Acquire Avidity Biosciences: A Major Biotech Deal
Novartis' $12B RNA Therapeutics Breakthrough
Novartis' $12B RNA Therapeutics Breakthrough
Game Changer Alert: How Novartis’s $12B Deal Will Shake Up Biotech Portfolios!
Game Changer Alert: How Novartis’s $12B Deal Will Shake Up Biotech Portfolios!
🔥 Novartis шокирует Уолл-стрит: поглощение Avidity Biosciences за 12 миллиардов долларов! 🔥
🔥 Novartis шокирует Уолл-стрит: поглощение Avidity Biosciences за 12 миллиардов долларов! 🔥
Novartis Acquires Avidity Biosciences: $12B Health Care Deal Breakdown
Novartis Acquires Avidity Biosciences: $12B Health Care Deal Breakdown
Novartis покупает Avidity | Станет ли биотехнология следующим крупным бумом для инвесторов?
Novartis покупает Avidity | Станет ли биотехнология следующим крупным бумом для инвесторов?
Novartis to Buy Avidity for $12 Billion RNA’s Next Big Bet
Novartis to Buy Avidity for $12 Billion RNA’s Next Big Bet
Novartis Acquires Avidity Biosciences: A $12 Billion Deal
Novartis Acquires Avidity Biosciences: A $12 Billion Deal
Novartis Acquires Avidity Biosciences: Revolutionizing RNA Therapeutics for Neuromuscular Diseases
Novartis Acquires Avidity Biosciences: Revolutionizing RNA Therapeutics for Neuromuscular Diseases
Novartis “on track” to bring one of the most expensive drugs to Europe
Novartis “on track” to bring one of the most expensive drugs to Europe
Доктор Норман Путцки, доктор медицинских наук — Novartis — Генная терапия и новая эра нейронауки
Доктор Норман Путцки, доктор медицинских наук — Novartis — Генная терапия и новая эра нейронауки
Silence Therapeutics CEO talks recent RNAi deals and updates on critical SLN124 trial
Silence Therapeutics CEO talks recent RNAi deals and updates on critical SLN124 trial
Novartis Q3 2025: уверенный рост, сделка с Avidity на 12 млрд долларов и объяснение падения EPS
Novartis Q3 2025: уверенный рост, сделка с Avidity на 12 млрд долларов и объяснение падения EPS